8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
May 23, 2011 (May 19, 2011)

AMSURG CORP.

(Exact Name of Registrant as Specified in Charter)

Tennessee
(State or Other Jurisdiction of
Incorporation) 000-22217
(Commission
File Number) 62-1493316
(I.R.S. Employer
Identification No.)

20 Burton Hills Boulevard
Nashville, Tennessee (Address of Principal Executive Offices)	37215 (Zip Code)

(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     On May 19, 2011, the board of directors (the “Board”) of AmSurg Corp. (the “Company”) appointed Cynthia S. Miller to serve as a Class III director of the Company. The Board did not appoint Ms. Miller to serve as a member of any of the committees of the Board.

     Effective May 19, 2011, the Company approved a grant of restricted common stock to Ms. Miller pursuant to the Company’s 2006 Stock Incentive Plan, as amended, having a fair market value on the date of grant equal to $60,000. The shares of restricted common stock shall vest in equal installments on each of the first and second anniversaries of the date of grant, provided that Ms. Miller is still a director of the Company on such dates.

     Ms. Miller is not a party to any arrangement or understanding with any person pursuant to which Ms. Miller was appointed as a director, nor is Ms. Miller a party to any transaction, or series of transactions, required to be disclosed pursuant to Item 404(a) of Regulation S-K.

     A copy of the press release announcing Ms. Miller’s appointment to the Board is included herewith as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

     (d) Exhibits

99.1 Press Release

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMSURG CORP.
By:	/s/ Claire M. Gulmi
	Claire M. Gulmi
	Executive Vice President, Chief Financial Officer and Secretary (Principal Financial and Duly Authorized Officer)

Date: May 23, 2011

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE	Contact:	Claire M. Gulmi
		Executive Vice President and
		Chief Financial Officer
		(615) 665-1283

AMSURG NAMES VETERAN HEALTHCARE EXECUTIVE CINDY MILLER TO
BOARD OF DIRECTORS

NASHVILLE, Tenn. — (May 23, 2011) — Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced the appointment of Cynthia S. Miller to its Board of Directors. Ms. Miller recently joined Univita, a provider of extended care and home care services, as Senior Vice President of Innovation and Pricing. Previously, she was with WellPoint, Inc. since 2004 and its predecessor, Anthem, Inc., which she joined in 1986. At WellPoint, Ms. Miller served as Executive Vice President and Chief Actuary, through which she was involved in pricing, product development, valuation, healthcare management support, mergers and acquisitions, forecasting and strategic planning related to health care reform. She also served as Senior Vice president and Chief of Staff to the CEO of WellPoint, responsible for, among other things, the design and execution of key corporate management initiatives. At Anthem, Ms. Miller was Vice President and Chief Actuary. During her tenure, she also had responsibility for the company’s risk management functions and led its merger, acquisition and divestiture activities. Ms. Miller received her Bachelor of Science degree from The Ohio State University and her Master of Arts degree in Mathematics from Indiana University.

     “AmSurg is pleased to announce the addition of Cindy Miller to our Board of Directors,” remarked Mr. Holden. “She has developed a strong reputation as an effective leader in her 25-year healthcare career, with in-depth experience in managed care and integrated healthcare systems management. We are confident that she brings a valuable strategic perspective as an independent director to our Board, and we look forward to her contributions to the long-term growth of the Company.”

     AmSurg Corp. acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States. At March 31, 2011, AmSurg owned a majority interest in 203 continuing centers in operation and had one center under development.

— END —